Literature DB >> 26952271

Relation of Cardiac Dysfunction to Rhythm Abnormalities in Patients With Duchenne or Becker Muscular Dystrophies.

David Y Chiang1, Hugh D Allen2, Jeffrey J Kim2, Santiago O Valdes2, Yunfei Wang2, Ricardo H Pignatelli2, Timothy E Lotze3, Christina Y Miyake4.   

Abstract

The association between systolic cardiac dysfunction and arrhythmia development in patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) is generally assumed but has not been extensively studied. The purpose of this study was to describe arrhythmias in patients with DMD and BMD in the present era and determine whether arrhythmia development is associated with cardiac dysfunction. This is a single-center retrospective review of 237 Holters from 91 patients with DMD (mean = 17 ± 4 years, range 3 to 27 years) and 64 Holters from 21 patients with BMD (mean = 18 ± 7 years, range 4 to 31 years) with corresponding echocardiography. Holters were stratified by age of patient at the time of study and ejection fraction: normal (≥55%), mild (<55% and ≥45%), moderate (<45% and ≥30%), and severe (<30%). Arrhythmias included frequent atrial and ventricular premature complexes (>10/hr), couplets, and runs of supraventricular and ventricular tachycardias. Arrhythmias occurred in 44% of DMD and 57% of BMD patients and were significantly associated with decrease in cardiac function. Clinically significant arrhythmias (supraventricular tachycardia and ventricular tachycardia) occurred in 10% of all Holters obtained in patients with DMD and 25% of all Holters obtained in patients with BMD. Subgroup analysis of Holters from patients with DMD demonstrated that arrhythmias increased with decreasing ejection fraction regardless of age, but that age was also a significant predictor of arrhythmia development. In conclusion, among patients with DMD or BMD, arrhythmias increase with development of cardiac dysfunction.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26952271     DOI: 10.1016/j.amjcard.2016.01.031

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Electrical storm in a patient with Duchenne muscular dystrophy cardiomyopathy triggered by abrupt β-blocker interruption.

Authors:  Nikolaos Fragakis; Melani Sotiriadou; Lydia Krexi; Vassilios Vassilikos
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-06-15       Impact factor: 1.468

2.  Health Care Use of Cardiac Specialty Care in Children With Muscular Dystrophy in the United States.

Authors:  Erika J Mejia; Kimberly Y Lin; Oluwatimilehin Okunowo; Katherine A Iacobellis; Susan E Matesanz; John F Brandsema; Carol A Wittlieb-Weber; Hannah Katcoff; Heather Griffis; Jonathan B Edelson
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

Review 3.  Dystrophic Cardiomyopathy: Complex Pathobiological Processes to Generate Clinical Phenotype.

Authors:  Takeshi Tsuda; Kristi K Fitzgerald
Journal:  J Cardiovasc Dev Dis       Date:  2017-09-08

Review 4.  Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms.

Authors:  Alberto Palladino; Paola D'Ambrosio; Andrea Antonio Papa; Roberta Petillo; Chiara Orsini; Marianna Scutifero; Gerardo Nigro; Luisa Politano
Journal:  Acta Myol       Date:  2016-12

5.  Cardiac Dysfunction in Duchenne Muscular Dystrophy Is Less Frequent in Patients With Mutations in the Dystrophin Dp116 Coding Region Than in Other Regions.

Authors:  Tetsushi Yamamoto; Hiroyuki Awano; Zhujun Zhang; Mio Sakuma; Shoko Kitaaki; Masaaki Matsumoto; Masashi Nagai; Itsuko Sato; Takamitsu Imanishi; Nobuhide Hayashi; Masafumi Matsuo; Kazumoto Iijima; Jun Saegusa
Journal:  Circ Genom Precis Med       Date:  2018-01

Review 6.  Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results.

Authors:  Alberto Palladino; Andrea A Papa; Salvatore Morra; Vincenzo Russo; Manuela Ergoli; Anna Rago; Chiara Orsini; Gerardo Nigro; Luisa Politano
Journal:  Acta Myol       Date:  2019-03-01

7.  Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.

Authors:  Binyamin Eisen; Ronen Ben Jehuda; Ashley J Cuttitta; Lucy N Mekies; Yuval Shemer; Polina Baskin; Irina Reiter; Lubna Willi; Dov Freimark; Mihaela Gherghiceanu; Lorenzo Monserrat; Michaela Scherr; Denise Hilfiker-Kleiner; Michael Arad; Daniel E Michele; Ofer Binah
Journal:  J Cell Mol Med       Date:  2019-01-08       Impact factor: 5.310

Review 8.  Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.

Authors:  Britt Hanson; Matthew J A Wood; Thomas C Roberts
Journal:  RNA Biol       Date:  2021-01-20       Impact factor: 4.652

Review 9.  Voltage-Dependent Sarcolemmal Ion Channel Abnormalities in the Dystrophin-Deficient Heart.

Authors:  Xaver Koenig; Janine Ebner; Karlheinz Hilber
Journal:  Int J Mol Sci       Date:  2018-10-23       Impact factor: 6.208

10.  Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers.

Authors:  Ursula M Hiermeier; Christine Baker; John P Bourke
Journal:  Open Heart       Date:  2020-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.